Search Results - "Wan, Zesheng"
-
1
TGFβR1 Blockade with Galunisertib (LY2157299) Enhances Anti-Neuroblastoma Activity of the Anti-GD2 Antibody Dinutuximab (ch14.18) with Natural Killer Cells
Published in Clinical cancer research (01-02-2017)“…Immunotherapy of high-risk neuroblastoma using the anti-GD2 antibody dinutuximab induces antibody-dependent cell-mediated cytotoxicity (ADCC). Galunisertib, an…”
Get full text
Journal Article -
2
Mechanism of Synergy of N-(4-Hydroxyphenyl)Retinamide and ABT-737 in Acute Lymphoblastic Leukemia Cell Lines: Mcl-1 Inactivation
Published in JNCI : Journal of the National Cancer Institute (16-04-2008)“…Background ABT-737 is a pan-Bcl-2 inhibitor that has a wide range of single-agent activity against acute lymphoblastic leukemia (ALL) cell lines and…”
Get full text
Journal Article -
3
Molecular mechanisms of Guadecitabine induced FGFR4 down regulation in alveolar rhabdomyosarcomas
Published in Neoplasia (New York, N.Y.) (01-07-2020)“…Fibroblast growth factor receptor 4 (FGFR4) aberrant expression and activity have been linked to the pathogenesis of a variety of cancers including…”
Get full text
Journal Article -
4
Histone Deacetylase 1 Gene Expression and Sensitization of Multidrug-Resistant Neuroblastoma Cell Lines to Cytotoxic Agents by Depsipeptide
Published in JNCI : Journal of the National Cancer Institute (18-07-2007)“…Background Genes that are overexpressed in multidrug-resistant neuroblastomas relative to drug-sensitive neuroblastomas may provide targets for modulating drug…”
Get full text
Journal Article -
5
Preclinical Evaluation of a Novel Dual Targeting PI3Kδ/BRD4 Inhibitor, SF2535, in B-Cell Acute Lymphoblastic Leukemia
Published in Frontiers in oncology (01-12-2021)“…The PI3K/Akt pathway-and in particular PI3Kδ-is known for its role in drug resistant B-cell acute lymphoblastic leukemia (B-ALL) and it is often upregulated in…”
Get full text
Journal Article -
6
Characterizing the Motility of Chemotherapeutics-Treated Acute Lymphoblastic Leukemia Cells by Time-Lapse Imaging
Published in Cells (Basel, Switzerland) (16-06-2020)“…Drug resistance is an obstacle in the therapy of acute lymphoblastic leukemia (ALL). Whether the physical properties such as the motility of the cells…”
Get full text
Journal Article -
7
Optimization of a Neural Stem-Cell-Mediated Carboxylesterase/Irinotecan Gene Therapy for Metastatic Neuroblastoma
Published in Molecular therapy. Oncolytics (17-03-2017)“…Despite improved survival for children with newly diagnosed neuroblastoma (NB), recurrent disease is a significant problem, with treatment options limited by…”
Get full text
Journal Article -
8
TBL1 Inhibitor, Tegavivint, Supresses Cell Survival and Promotes Sensitivity to Chemotherapy in ALL and AML
Published in Blood (15-11-2022)Get full text
Journal Article -
9
Activated Natural Killer Cells in Combination with Anti-GD2 Antibody Dinutuximab Improve Survival of Mice after Surgical Resection of Primary Neuroblastoma
Published in Clinical cancer research (01-01-2019)“…Immunotherapy of neuroblastoma that remains after myeloablative chemotherapy with anti-GD2 antibody dinutuximab has increased the two-year event-free and…”
Get full text
Journal Article -
10
The Role of Integrin Beta-1 in the Chemoresistance of Acute Myeloid Leukemia
Published in Blood (15-11-2022)Get full text
Journal Article -
11
Lenalidomide overcomes suppression of human natural killer cell anti-tumor functions by neuroblastoma microenvironment-associated IL-6 and TGFβ1
Published in Cancer Immunology, Immunotherapy (01-10-2013)“…Background Treatment for children with high-risk neuroblastoma with anti-disialoganglioside mAb ch14.18, IL-2, and GM-CSF plus 13- cis -retinoic acid after…”
Get full text
Journal Article -
12
Lenalidomide overcomes suppression of human natural killer cell anti-tumor functions by neuroblastoma microenvironment-associated IL-6 and TGF beta 1
Published in Cancer Immunology, Immunotherapy (01-10-2013)“…Background: Treatment for children with high-risk neuroblastoma with anti-disialoganglioside mAb ch14.18, IL-2, and GM-CSF plus 13-cis-retinoic acid after…”
Get full text
Journal Article -
13
Abstract 5920: Inhibition of TBL1 and β-catenin interaction sensitizes acute lymphoblastic leukemia to chemotherapy
Published in Cancer research (Chicago, Ill.) (22-03-2024)“…BACKGROUND: Relapse of T-cell acute lymphoblastic leukemia (T-ALL) and B-cell acute lymphoblastic leukemia (B-ALL) post-chemotherapy or post-immunotherapy…”
Get full text
Journal Article -
14
-
15
634. Translation of a Neural Stem Cell-Mediated Enzyme/Prodrug Gene Therapy for Metastatic Neuroblastoma
Published in Molecular therapy (01-05-2015)Get full text
Journal Article -
16
STEM-01NEURAL STEM CELL-MEDIATED ENZYME/PRODRUG THERAPY FOR NEUROBLASTOMA: TRANSLATION TO THE CLINIC
Published in Neuro-oncology (Charlottesville, Va.) (01-11-2015)Get full text
Journal Article -
17
Lenalidomide overcomes suppression of human natural killer cell anti-tumor functions by neuroblastoma microenvironment-associated IL-6 and TGF[beta]1
Published in Cancer immunology, immunotherapy (01-10-2013)“…Treatment for children with high-risk neuroblastoma with anti-disialoganglioside mAb ch14.18, IL-2, and GM-CSF plus 13-cis-retinoic acid after myeloablative…”
Get full text
Journal Article -
18
Epithelial-Mesenchymal Interactions Are Linked to Neovascularization
Published in American journal of respiratory cell and molecular biology (01-06-2004)“…Lung morphogenesis is dependent on interactions between mesenchymal and epithelial cells. We have previously demonstrated that inhibition of neovascularization…”
Get full text
Journal Article